Induction of endothelin-1 expression by glucose an effect of protein kinase C activation

Diabetes

Volumn 49, Issue 7, 2000, Pages 1239-1248

  Park, Joong Yeol ^a   Takahara, Noriko ^a   Gabriele, Annarita ^a   Chou, Eva ^a   Naruse, Keiko ^a   Suzuma, Kiyoshi ^a   Yamauchi, Teruaki ^a   Ha, Sung Woo ^a   Meier, Matthias ^a   Rhodes, Christopher J ^a   King, George L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CATTLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENZYME ACTIVATION; GLUCOSE METABOLISM; HYPERGLYCEMIA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASOCONSTRICTION;

EID: 0033949316     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.7.1239     Document Type: Article

References (55)

1. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
2. Feke GT, Buzney SM, Ogasawara H, Fujio N, Goger DG, Spack NP, Gabbay KH: Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci 35:2968-2975, 1994
3. Bursell SE, Clermont AC, Kinsley BT, Simonson DC, Aiello LM, Wolpert HA: Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci 37:886-897, 1996
4. Small KW, Stefansson E, Hatchell D: Retinal blood flow in normal and diabetic dogs. Invest Ophthalmol Vis Sci 28:672-675, 1987
5. Tesfaye S, Malik R, Ward JD: Vascular factors in diabetic neuropathy. Diabetologia 37:847-851, 1994
6. + ATPase defects in diabetic rats (Abstract). Diabetes 46 (Suppl. 1):31A, 1997
7. Shiba T, Inoguchi T, Sportsman R, Heath WF, Bursell SE, King GL: Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265:E783-E793, 1993
8. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor. Science 272:728-731, 1996
9. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
10. Rai H, Hori S, Aramori I, Ohkubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732, 1990
11. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735, 1990
12. Karne S, Jayawickreme CK, Lerner MR: Cloning and characterization of an endothelin-3 specific receptor (ETc receptor) from Xenopus laevis dermal melanophores. J Biol Chem 25:19126-19133, 1993
13. Bursell SE, Clermont AC, Oren D, King GL: The in vivo effect of endothelin on retinal circulation in non-diabetic and diabetic rats. Invest Ophthalmol Vis Sci 36:596-607, 1995
14. Takaki C, Bursell S-E, Lin Y-W, Takaki H, Duh E, Jiang Z, Clermont AC, King GL: Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci 37:2054-2018, 1996
15. B receptor agonist. Life Sci 53:PL111-PL115, 1993
16. Cameron NE, Cotter MA: Effects of a non-peptide endothelin-1 ET-A antagonist on neurovascular function in diabetic rats: interaction with the renin-angiotensin system. J Pharmacol Exp Ther 278:1262-1268, 1996
17. Benatti L, Bonecchi L, Liviana C, Sarmientos P: Two endothelin-1 mRNAs transcribed by alternative promoter. J Clin Invest 91:1149-1156, 1993
18. Luscher TF, Boulanger CM, Dohi Y, Yang Z: Endothelium-derived contracting factors. Hypertension 19:117-130, 1992
19. Yamada Y, Yokoda M: Effects of protein kinase C activation and inhibition on endothelin-1 release from human aortic and pulmonary artery endothelial cells: comparison with effects on bovine endothelin-1 and human prostaglandin 12 release. Am J Hypertens 10:32-42, 1997
20. Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F: Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension 18:165-170, 1991
21. Hattori Y, Kasai K, Banba N, Hattori S, Nakamura T, Shimoda S: Effects of a phorbol ester on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells. Endocrinol Jpn 39:341-345, 1992
22. Baumgartner-Parzer SM, Wagner L, Reining G, Sexl V, Nowotny P, Muller M, Brunner M, Waldhausl W: Increase by tri-iodothyronine of endothelin-1, fibronectin and von Willebrand factor in cultured endothelial cells. J Endocrinol 154:231-239, 1997
23. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
24. U.K. Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
25. U.K. Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
26. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform β II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A 89:11059-11063, 1992
27. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43:1122-1129, 1994
28. Babazono T, Kapor-Drezgic J, Dlugosz JA, Whiteseide C: Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 47:668-676, 1998
29. Kunisaki M, Bursell SE, Umeda F, Nawata H, King GL: Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43:1372-1377, 1995
30. Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H: Enhanced secretion of endothelin-1 by elevated glucose levels front cultured bovine aortic endothelial cells. FEBS Lett 267:16-18, 1990
31. King GL, Goodman AD, Buzney S, Moses A, Kahn CR: Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-1036, 1985
32. Nayak RC, Berman AB, George KL, Eisenbarth GS, King GL: A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J Exp Med 167:1003-1015, 1988
33. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chroloform extraction. Anal Biochem 162:156-159, 1987
34. Aiello LP, Robinson GS, Lin YW, Nishio Y, King GL: Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci U S A 91: 6231-6235, 1994
35. +-adenosine triphosphate by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 96:733-740, 1995
36. Yasuda I, Kishimoto A, Tanaka S, Tominaga M, Sakurai A, Nishizuka Y: A synthetic peptide substrate for selectivity assay of protein kinase C. Biochem Biophys Res Commun 166:1220-1227, 1990
37. Bradford MM: A rapid and sensitive method of the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
38. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, King GL: Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 267:E369-E379, 1994
39. Becker TC, BeltrandelRio H, Noel RJ, Johnson JH, Newgard CB: Overexpression of hexokinase I in isolated islet of Langerhans via recombinant adenovirus: enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. J Biol Chem 269:21234-21238, 1994
40. Becker TC, Noel RJ, Coats WS, Gomez-Foix AM, Alam T, Gerard RD, Newgard CB: Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol 43:161-189, 1994
41. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
42. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald JH 3rd, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, Baevsky M, Ballas LM, Hall SE, Winneroski LL, Faul MM: (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C β. J Med Chem 39:2664-2671, 1996
43. Makino A, Kamata K: Elevated plasma endothelin-1 level in streptozotocin induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br J Pharmacol 123:1065-1072, 1998
44. Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH: Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 5:161-166, 1992
45. Clermont AC, Brittis M, Shiba T, McGovern T, King GL, Bursell S-E: Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci 35:981-990, 1994
46. Williams B, Schreier RW: Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes 41: 1464-1472, 1992
47. Chakrabarti S, Sima AA: Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. Diabetes Res Clin Pract 37:109-120, 1997
48. Chakrabarthy U, Hayes RG, Stitt AW, Douglas A: Endothelin expression in ocular tissues of diabetic and insulin-treated rats. Invest Ophthalmol Vis Sci 38:2144-2155, 1997
49. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577, 1991
50. Haller H, Baur E, Quass P, Behrend M, Lindschau C, Distler A, Luft FC: High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 47:1057-1067, 1995
51. Berti L, Mosthaf L, Kroder G, Kellerer M, Tippmer S, Mushack J, Seffer E, Klaus Seedorf, Haring H: Glucose-induced translocation of protein kinase C isoforms in Rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J Biol Chem 269:3381-3386, 1994
52. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang Z-Y, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL: Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103:185-195, 1999
53. Inoue A, Yanagisawa M, Takuwa Y, Mitsui Y, Kobayashi M, Masaki T: The human preproendothelin-1 gene: complete nucleotide sequence and regulation of expression. J Biol Chem 254:14954-14959, 1989
54. Lee M-E, Dhadly MS, Temizer DH, Clifford JA, Yoshizumi M, Quertermous T: Regulation of endothelin-1 gene expression by fos and jun. J Biol Chem 265:19034-19039, 1991
55. Soh JW, Lee EH, Prywes R, Weinstein IB: Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol Cell Biol 19:1313-1324, 1999